Estimation of pulse pressure in subjects with metabolic syndrome;Ocena ciśnienia tȩtna u pacjentów z zespołem metabolicznym

Polski Merkuriusz Lekarski

Volumn 23, Issue 133, 2007, Pages 36-40

  Kowalski, Jan ^a   Barylski, Marcin ^a   Krzemińska, Anna ^a   Irzmański, Robert ^a   Pawlicki, Lucjan ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cardiovascular risk; Metabolic syndrome; Pulse pressure

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMORBIDITY; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; PULSATILE FLOW; PULSE RATE; REFERENCE VALUE; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PROGNOSIS; PULSATILE FLOW; PULSE; REFERENCE VALUES; RISK FACTORS;

EID: 34547822569     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Airaksinen K.E., Salmela P.I., Linnaluoto M.K.: Diminished arterial elasticity in diabetes: Association with fluorescent advanced glycosylation and products in collagen. Cardiovascular Res., 1993, 27, 942-945.
2. Cockroft J.R., Webb D.J., Wilkinson I.B.: Arterial stiffness, hypertension and diabetes mellitus. J. Hum. Hypertens., 2000, 14, 377-380.
3. Covic A., Haydar A.A., Bharma-Ariza P. i wsp: Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J. Nephrol., 2005, 18, 388-396.
4. Cwynar M., Wojciechowska W., Kawecka-Jaszcz K. i wsp.: Mechanizmy przebudowy dużych naczyń tȩtniczych. Przegl. Lek., 2002, 59, supl. 3, 1-8.
5. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesaterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
6. Ford E.S., Giles W.H.: A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care, 2003, 26, 575-581.
7. Franklin S.S., Khan S.A., Wong N.D. i wsp.: Is pulse pressure useful in predicting risk for coronary heart disease. The Frammingham Heart Study. Circulation, 1999, 100, 354-360.
8. Gryglewska B., Ga̧sowski J., Grodzicki T. i wsp.: Ciśnienie tȩtna nowy czynnik ryzyka powiklań sercowo-naczyniowych. Terapia, 2000, 9, 57-63.
9. Gural J., Widecka J., Widecka K. i wsp.: Wpływ leptyny na wybrane wskażniki kliniczne i biochemiczne u chorych na samoistne nadciśnienie tȩtnicze z zespołem metabolicznym i bez tego zespolu. Nadciśnienie tȩtnicze, 2006, 10, 251-258.
10. Isomaa B., Almgren P., Tuomi T. i wsp.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24, 683-689.
11. Lakka H.M., Laaksonen D.E., Lakka T.A. i wsp.: The metabolic syndrome and the total and cardiovascular disease mortality in middle aged men. JAMA, 2002, 288, 2709-2716.
12. Malik S., Wong N.D., Franklin S.S. i wsp.: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation, 2004, 110, 1245-1250.
13. Neaton J.D., Wentworth D.: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316.099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med., 1992, 152, 56-64.
14. O'Rourke MF, Adji A.: An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry. Curr. Opin. Card., 2005, 20, 275-281.
15. Pȩdzik E., Szmigielski C., Gaciong Z.: Ciśnienie centralne jako wskaźnik ryzyka powikłań sercowo-naczyniowych. Nadciśnienie tȩtnicze, 2006, 10, 341-349.
16. Sader S., Nian M., Liu P.: Leptin: a novel link between obesity, diabetes, cardiovascular risk and ventricular hypertrophy. Circulation, 2003, 108, 644-646.
17. Sławuta A., Witkowski M.: Ciśnienie tȩtna a wybrane biochemiczne czynniki ryzyka powiklań sercowo-naczyniowych u chorych na nadciśnienie tȩtnicze pierwotne. Nadciśnienie tȩtnicze, 2006, 10, 190-196.
18. Smulyan H., Safar M. E.: The diastolic blood pressure in systolic hypertension. Ann. Intern. Med., 2000, 32, 233-237.
19. Szczepaniak-Chichet L., Mastej M., Piwowarska W. i wsp.: Wystȩpowanie metabolicznych czynników ryzyka sercowo-naczyniowego u chorych na nadciśnienie tȩtnicze i u pacjentówz prawidlowymi wartościami ciśnienia w populacji polskiej badania LIPIDOGRAM 2004. Nadciśnienie tȩtnicze, 2006, 10, 377-391.
20. Tzou W., Douglas P.S., Srlnivasan S.R. i wsp.: Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J. Am. Coll. Cardiol., 2005, 46, 457-463.
21. Wautier J.L., Schmidt A.M.: Protein glycation - a firm link to endothelial cell dysfunction. Circ. Res., 2004,95, 233-238.